Cargando…

Defining the phenotype, pathogenesis and treatment of Crohn’s disease associated spondyloarthritis

Peripheral and axial spondyloarthritis are the most common extra-intestinal manifestations reported in patients with Crohn’s disease. Despite the frequency of Crohn’s disease associated spondyloarthritis, clinical diagnostic tools are variably applied in these cohorts and further characterization wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Anand, Lukin, Dana, Battat, Robert, Schwartzman, Monica, Mandl, Lisa A., Scherl, Ellen, Longman, Randy S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297835/ https://www.ncbi.nlm.nih.gov/pubmed/32367294 http://dx.doi.org/10.1007/s00535-020-01692-w

Ejemplares similares

The Impact of Confounders on Symptom–Endoscopic Discordances in Crohn’s Disease
por: Rajan, Anjana, et al.
Publicado: (2023)

Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease
por: Kumar, Anand, et al.
Publicado: (2020)

Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination
por: Charilaou, Paris, et al.
Publicado: (2022)

Su1487: IMPACT OF INFLAMMATORY BOWEL DISEASE THERAPIES ON DURABILITY OF HUMORAL RESPONSE TO SARS COV-2 VACCINATION
por: Charilaou, Paris, et al.
Publicado: (2022)

Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease
por: Gordon, Benjamin Langan, et al.
Publicado: (2022)

Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease
por: Wong, Rochelle, et al.
Publicado: (2023)

Joint Disease Activity in Inflammatory Bowel Disease–associated Peripheral Spondyloarthritis Stratifies Therapeutic Response
por: LAI, D., et al.
Publicado: (2022)

Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease
por: Lukin, Dana J., et al.
Publicado: (2020)

No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD
por: Lukin, Dana J., et al.
Publicado: (2021)

Novel immune cell phenotypes in spondyloarthritis pathogenesis
por: Mauro, Daniele, et al.
Publicado: (2021)

Understanding the Pathogenesis of Spondyloarthritis
por: Sharip, Aigul, et al.
Publicado: (2020)

Circulating mature granzyme B+ T cells distinguish Crohn’s disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn’s disease
por: Lefferts, Adam R., et al.
Publicado: (2021)

Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis
por: Jadon, Deepak R, et al.
Publicado: (2017)

Serum Ustekinumab Concentrations Are Associated With Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index
por: Walshe, Margaret, et al.
Publicado: (2021)

Mycobacterium avium subspecies paratuberculosis (MAP) and Crohn’s disease: the debate continues
por: Mintz, Michael J., et al.
Publicado: (2023)

BSR Spondyloarthritis Course, 27 February 2020. Spondyloarthritis: pathogenesis, diagnosis and management
por: Marzo-Ortega, Helena, et al.
Publicado: (2020)

Defining the target: clinical aims in axial spondyloarthritis
por: Marzo-Ortega, Helena, et al.
Publicado: (2018)

Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis
por: Rizzo, Aroldo, et al.
Publicado: (2018)

Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease
por: Zhang, Shiying, et al.
Publicado: (2022)

Pathogenesis of Crohn's disease
por: Boyapati, Ray, et al.
Publicado: (2015)

Vitamin C Deficiency: An Under-Recognized Condition in Crohn's Disease
por: Gordon, Benjamin L., et al.
Publicado: (2020)

Identification of genes and signaling pathways associated with the pathogenesis of juvenile spondyloarthritis
por: Wang, Zhe, et al.
Publicado: (2018)

The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
por: Tsukazaki, Hiroyuki, et al.
Publicado: (2020)

Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs
por: Schwartzman, Monica, et al.
Publicado: (2022)

Metabolomics: An Emerging Approach to Understand Pathogenesis and to Assess Diagnosis and Response to Treatment in Spondyloarthritis
por: Rizzo, Chiara, et al.
Publicado: (2022)

The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology
por: Malaviya, Anand N., et al.
Publicado: (2017)

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications
por: Felice, Carla, et al.
Publicado: (2023)

Identifying phenotypes of COVID-19, defining their pathogenesis, and targeting treatments could improve outcomes
por: Rajendram, Rajkumar, et al.
Publicado: (2020)

Efficacy of Ustekinumab Against Spondyloarthritis Associated with Crohn’s Disease: A Case Report and Review of the Literature
por: Matsumoto, Satohiro, et al.
Publicado: (2020)

A rolling phenotype in Crohn's disease
por: Irwin, James, et al.
Publicado: (2017)

An Audit of Crohn's Disease in a Defined Population
por: Mayberry, J. F., et al.
Publicado: (1983)

A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
por: McInnes, Iain B, et al.
Publicado: (2021)

494. Enteric bacteria are immune-reactive in patients with Crohn's disease with extraintestinal manifestations
por: Maldarelli, Grace A, et al.
Publicado: (2022)

Role of HLA typing on Crohn's disease pathogenesis
por: Mahdi, Batool Mutar
Publicado: (2015)

The role of epigenetic modifications for the pathogenesis of Crohn's disease
por: Hornschuh, M., et al.
Publicado: (2021)

Pathogenesis of Fistulating Crohn’s Disease: A Review
por: McGregor, Colleen Georgette Chantelle, et al.
Publicado: (2022)

Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach
por: Charilaou, Paris, et al.
Publicado: (2022)

Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors
por: Moz, Stefania, et al.
Publicado: (2017)

Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study
por: Conigliaro, Paola, et al.
Publicado: (2021)

Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn’s disease
por: Holmer, Ariela K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nt53gvjfufb22qdffrjm2upnh5